SCHEMBL20588441

SCHEMBL20588441

C[Si](C)(C)CCOCn1cc(Br)c2c(Oc3c(F)cc(NC(=O)NCCNS(C)(=O)=O)cc3F)ccnc21

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.32
OPRK1 P41145 1/20 0.32
MAP4K1 Q92918 1/20 0.32
TBK1 Q9UHD2 1/20 0.32
MET P08581 3/20 0.31
BRAF P15056 1/20 0.30
EGFR P00533 1/20 0.30
IGF1R P08069 1/20 0.30
KIT P10721 1/20 0.30
SRC P12931 1/20 0.30
AXL P30530 1/20 0.30
KDR P35968 1/20 0.30
MST1R Q04912 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
PTPN2 P17706 1/20 0.30
PTPN1 P18031 1/20 0.30
PTPN6 P29350 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20588595 0.92 MAP4K1 (0.34) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20587700 0.91 MAP4K1 (0.36) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20588297 0.91 MAP4K1 (0.38) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20588679 0.90 MET (0.35) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20587523 0.88 MAP4K1 (0.35) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20587612 0.88 ROCK2 (0.33) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20588349 0.88 MAP4K1 (0.35) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20588769 0.87 ROCK2 (0.34) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20588354 0.87 TBK1 (0.36) ROCK2OPRK1MAP4K1TBK1MET
SCHEMBL20587966 0.86 TBK1 (0.35) ROCK2OPRK1MAP4K1TBK1MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3638669-A1 SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES Bayer Pharma Aktiengesellschaft (DE) 2020-04-22 EP disclosed
WO-2018228920-A1 SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-12-20 WO disclosed